Sana Biotechnology (SANA) Cash from Operations (2020 - 2026)
Sana Biotechnology (SANA) reported Cash from Operations of 37379000.0 for Q1 2026, up 23.18% on a YoY basis from 30345374.21 in Q1 2025, and down 14.52% sequentially from 32641000.0 in Q4 2025.
Sana Biotechnology (SANA) Cash from Operations (2020 - 2026) Analysis & Trends
Sana Biotechnology (SANA) has 7 years of Cash from Operations data on file, last reported at 37379000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 23.18% year-over-year to 37379000.0; the trailing twelve-month figure through Mar 2026 stood at 132550000.0 (up 35.71% YoY), and the FY2025 full-year result was 143828000.0, up 35.55% from the prior year.
- Cash from Operations slipped to 37379000.0 in Q1 2026, from 32641000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 29429000.0 in Q3 2025 to a low of 79272000.0 in Q1 2023.
- A 5-year average of 55764235.29 and a median of 58541000.0 in 2024 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations plunged 76.25% in 2022 and soared 43.46% in 2025, its largest moves.
- Tracing SANA's Cash from Operations over 5 years: stood at 76067000.0 in 2022, then soared by 31.69% to 51959000.0 in 2023, then grew by 9.23% to 47161000.0 in 2024, then jumped by 30.79% to 32641000.0 in 2025, then retreated by 14.52% to 37379000.0 in 2026.
- Business Quant data shows SANA's Cash from Operations at 37379000.0 in Q1 2026, 32641000.0 in Q4 2025, and 29429000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Sana Biotechnology | 888.71 Mn | 888.71 Mn | - | -37.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.38 Mn |
| Mar 31, 2026 | -37.38 Mn |
| Dec 31, 2025 | -32.64 Mn |
| Dec 31, 2025 | -32.64 Mn |
| Sep 30, 2025 | -29.43 Mn |
| Sep 30, 2025 | -29.43 Mn |
| Jun 30, 2025 | -33.10 Mn |
| Jun 30, 2025 | -33.10 Mn |
| Mar 31, 2025 | -48.66 Mn |
| Mar 31, 2025 | -48.66 Mn |
| Dec 31, 2024 | -47.16 Mn |
| Dec 31, 2024 | -47.16 Mn |
| Sep 30, 2024 | -51.82 Mn |
| Sep 30, 2024 | -51.82 Mn |
| Jun 30, 2024 | -58.54 Mn |
| Jun 30, 2024 | -58.54 Mn |
| Mar 31, 2024 | -65.63 Mn |
| Mar 31, 2024 | -65.63 Mn |
| Dec 31, 2023 | -51.96 Mn |
| Dec 31, 2023 | -51.96 Mn |